Similarly, our study supports a selective approach, as while 21.2% of patients experienced postoperative anemia, only 8.2% had severe cases (Hb <8 g/dL), emphasizing the need for risk-based monitoring. This evidence concerns the gene GSTM1 and anemia (phenotype).